Citius Oncology, Inc. Common Stock (CTOR)
Citius Oncology, Inc. Common Stock (CTOR) has reported earnings 7 times since Dec 27, 2024. The stock moves an average of ±5.00% the day after reporting, closing higher 57.1% of the time. Its largest post-earnings gain was +5.62% (Aug 12, 2025) and its largest decline was -16.78% (May 15, 2026). The next earnings report is predicted for 2026-12-25 (estimated).
Earnings reactions
How CTOR moved on each past earnings report.
Earnings Impact
Total Earnings
7
Avg Abs. Movement
±5.00%
Positive %
57.1%
Negative %
42.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 14, 2026 | ☽ POST | +0% | open_in_new |
| May 15, 2026 | ☽ POST | -16.78% | open_in_new |
| Feb 13, 2026 | ☀ PRE | +1.69% | open_in_new |
| Dec 23, 2025 | ☽ POST | -9.84% | open_in_new |
Earnings Count
7
Total earnings in dataset
Avg Abs. Movement
±5.00%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| ARS | 20260826 | open_in_new SEC.gov |
| DEF 14A | 20260826 | open_in_new SEC.gov |
| 10-Q | 20260814 | open_in_new SEC.gov |
| 3 | 20260814 | open_in_new SEC.gov |
| 424B3 | 20260814 | open_in_new SEC.gov |
| 8-K | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 8-K | 20260812 | open_in_new SEC.gov |
| 424B3 | 20260805 | open_in_new SEC.gov |
| 8-K | 20260805 | open_in_new SEC.gov |
Frequently asked about CTOR earnings
When does Citius Oncology, Inc. Common Stock report earnings next? expand_more
Citius Oncology, Inc. Common Stock (CTOR)'s next earnings date is estimated for 2026-12-25. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does CTOR stock move after earnings? expand_more
Over 7 reports, CTOR has moved an average of ±5.00% the session after earnings, closing higher 57.1% of the time.
What was CTOR's biggest post-earnings move? expand_more
CTOR's largest post-earnings gain on record was +5.62% on Aug 12, 2025, and its largest decline was -16.78% on May 15, 2026.
Where can I find Citius Oncology, Inc. Common Stock's SEC filings? expand_more
All of Citius Oncology, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right